Problems with sleep likely develop before motor symptoms in people with amyotrophic lateral sclerosis, a new study shows.

For most of us, getting less than seven hours of sleep translates into grogginess, sluggish thinking, and an overwhelming ...

Idorsia has become the first drugmaker in the EU to claim approval for a drug for chronic insomnia in the dual orexin receptor antagonist class, ahead of rival drugs from Merck & Co and Eisai.

Amyotrophic lateral sclerosis (ALS), also known as Charcot’s disease, or Lou Gehrig’s disease, is a severe neurodegenerative ...

Bial-Portela & Ca SA has identified orexin OX1 receptor antagonists reported to be useful for the treatment of cognitive, sleep, anxiety and eating disorders, depression, obesity, schizophrenia, ...

根据美国证券交易委员会的Form 4文件显示，市值57.7亿美元、在InvestingPro获得"GREAT"财务健康评分的制药公司Alkermes plc (NASDAQ: ALKS )财务副总裁兼临时首席会计官Samuel Joseph Parisi近期进行了一系列股票交易。2月20日，Parisi根据其在2024年9月制定的Rule ...

Dieting is no longer as simple as just eating boiled foods. We live in an age where not only what you eat, but when you eat, ...

Scheduled Feeding improved sleep/wake rhythms in the Fmr1 KO mutants.

Good morning, and welcome to the Axsome Therapeutics' fourth quarter and full year 2024 conference call. Currently, all participants are in listen-only mode. Later, there will be a question-and-answer ...